• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝 X 受体:从代谢到癌症。

Liver X receptor: from metabolism to cancer.

出版信息

Biochem J. 2014 Apr 15;459(2):e1-3. doi: 10.1042/BJ20140211.

DOI:10.1042/BJ20140211
PMID:24678940
Abstract

Cholesterol plays an indispensable role in regulating the properties of cell membranes in mammalian cells. Accumulation of cholesterol and its intermediates, such as oxysterols, lead to activation of the nuclear receptors LXRs (liver X receptors). LXR is an important regulator of cholesterol homoeostasis by controlling its transport and its neo-synthesis. Accumulating evidence indicates that the endogenous ligands of LXRs, oxysterols, play an active and important role in regulating the fate and function of immune cells. Indeed, LXRs are negative regu-lators of innate immunity by interfering with macrophage activation. Recent advances have highlighted a controversial role for LXR in cancer. In this issue of the Biochemical Journal, Wang et al. propose that LXR agonist directly controls IFN-γ (interferon-γ) expression, which limits tumour growth. This protective effect mediated by LXR appears to be dependent on IFN-γ. Thus, despite accumulation of endogenous ligand of LXR in cancer, activation of LXR seems protective. This novel evidence provides a new perspective for targeting LXR in cancer, although controversial studies can be also found in the literature. In order to avoid side effects associated with LXR agonists, molecular and cellular studies are required to decipher this unexpected action of LXRs.

摘要

胆固醇在调节哺乳动物细胞膜特性方面起着不可或缺的作用。胆固醇及其中间产物(如氧化固醇)的积累会导致核受体 LXR(肝 X 受体)的激活。LXR 是通过控制胆固醇的运输和新合成来调节胆固醇稳态的重要调节剂。越来越多的证据表明,LXR 的内源性配体氧化固醇在调节免疫细胞的命运和功能方面发挥着积极而重要的作用。事实上,LXR 通过干扰巨噬细胞的激活来负调控先天免疫。最近的进展强调了 LXR 在癌症中的争议作用。在本期《生物化学杂志》中,Wang 等人提出 LXR 激动剂直接控制 IFN-γ(干扰素-γ)的表达,从而限制肿瘤生长。这种由 LXR 介导的保护作用似乎依赖于 IFN-γ。因此,尽管癌症中 LXR 的内源性配体积累,但 LXR 的激活似乎具有保护作用。尽管文献中也有争议性的研究,但这一新证据为癌症中靶向 LXR 提供了新的视角。为了避免与 LXR 激动剂相关的副作用,需要进行分子和细胞研究来破译 LXR 的这种意外作用。

相似文献

1
Liver X receptor: from metabolism to cancer.肝 X 受体:从代谢到癌症。
Biochem J. 2014 Apr 15;459(2):e1-3. doi: 10.1042/BJ20140211.
2
Reciprocal negative cross-talk between liver X receptors (LXRs) and STAT1: effects on IFN-γ-induced inflammatory responses and LXR-dependent gene expression.肝 X 受体(LXRs)与 STAT1 之间的相互负反馈:对 IFN-γ 诱导的炎症反应和 LXR 依赖性基因表达的影响。
J Immunol. 2013 Jun 15;190(12):6520-32. doi: 10.4049/jimmunol.1201393. Epub 2013 May 17.
3
Identification of interferon-γ as a new molecular target of liver X receptor.鉴定干扰素-γ为肝 X 受体的一个新的分子靶标。
Biochem J. 2014 Apr 15;459(2):345-54. doi: 10.1042/BJ20131442.
4
Functional crosstalk of CAR-LXR and ROR-LXR in drug metabolism and lipid metabolism.CAR-LXR 和 ROR-LXR 在药物代谢和脂质代谢中的功能串扰。
Adv Drug Deliv Rev. 2010 Oct 30;62(13):1316-21. doi: 10.1016/j.addr.2010.07.006. Epub 2010 Jul 24.
5
Oxysterol receptors and their therapeutic applications in cancer conditions.氧化固醇受体及其在癌症治疗中的应用。
Expert Opin Ther Targets. 2013 Sep;17(9):1029-38. doi: 10.1517/14728222.2013.820708. Epub 2013 Jul 22.
6
Targeting liver X receptors in inflammation.靶向炎症中的肝 X 受体。
Expert Opin Ther Targets. 2013 Aug;17(8):977-90. doi: 10.1517/14728222.2013.806490. Epub 2013 Jun 6.
7
Uncoupling nuclear receptor LXR and cholesterol metabolism in cancer.在癌症中解偶联核受体 LXR 和胆固醇代谢。
Cell Metab. 2015 Apr 7;21(4):517-26. doi: 10.1016/j.cmet.2015.03.002.
8
Liver X receptors interact with corepressors to regulate gene expression.肝脏X受体与共抑制因子相互作用以调节基因表达。
Mol Endocrinol. 2003 Jun;17(6):1019-26. doi: 10.1210/me.2002-0399. Epub 2003 Mar 27.
9
Inhibition of tumor growth by U0126 is associated with induction of interferon-γ production.U0126 的抑瘤作用与干扰素-γ产生的诱导有关。
Int J Cancer. 2015 Feb 15;136(4):771-83. doi: 10.1002/ijc.29038. Epub 2014 Jun 28.
10
The liver X receptor: control of cellular lipid homeostasis and beyond Implications for drug design.肝 X 受体:细胞脂质稳态的调控及药物设计的意义。
Prog Lipid Res. 2010 Oct;49(4):343-52. doi: 10.1016/j.plipres.2010.03.002. Epub 2010 Apr 2.

引用本文的文献

1
Inhibition of Pancreatic Cancer Cell-Induced Paracrine Hedgehog Signaling by Liver X Receptor Agonists and Oxy16, a Naturally Occurring Oxysterol.肝脏X受体激动剂和天然存在的氧化甾醇Oxy16对胰腺癌细胞诱导的旁分泌刺猬信号通路的抑制作用
J Cell Biochem. 2017 Mar;118(3):499-509. doi: 10.1002/jcb.25668. Epub 2016 Sep 21.
2
Nuclear Receptors as Therapeutic Targets in Liver Disease: Are We There Yet?核受体作为肝脏疾病的治疗靶点:我们做到了吗?
Annu Rev Pharmacol Toxicol. 2016;56:605-626. doi: 10.1146/annurev-pharmtox-010715-103209.
3
Activation of the Liver X Receptor by Agonist TO901317 Improves Hepatic Insulin Resistance via Suppressing Reactive Oxygen Species and JNK Pathway.
激动剂TO901317激活肝脏X受体通过抑制活性氧和JNK信号通路改善肝脏胰岛素抵抗。
PLoS One. 2015 Apr 24;10(4):e0124778. doi: 10.1371/journal.pone.0124778. eCollection 2015.